PulseAugur
EN
LIVE 06:54:41

ByteDance spin-off Anew Labs raises $290M for AI drug discovery

By PulseAugur Editorial · [1 sources] ·

Anew Labs, a former unit of ByteDance, has secured US$290 million in funding at a US$1.5 billion valuation. The Shanghai-based AI drug discovery firm's funding round was backed by prominent venture capital firms including HSG (formerly Sequoia China), IDG Capital, and 5Y Capital. Anew Labs utilizes AI models for biomolecular structure prediction and design, including its own AnewFold model and an open-source version of Google DeepMind's AlphaFold 3. AI

IMPACT Accelerates AI's role in drug design and signals strong investor confidence in AI-driven pharmaceutical innovation.

RANK_REASON Significant funding round for an AI drug discovery startup. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on SCMP — Tech →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

ByteDance spin-off Anew Labs raises $290M for AI drug discovery

How we ranked this

Signal score
12 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
Significant funding round for an AI drug discovery startup. [lever_c_demoted from significant: ic=1 ai=0.7]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
funding, product, model release
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
Breaking (< 6h)
Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

Full methodology in our editorial standards.

COVERAGE [1]

  1. SCMP — Tech TIER_1 English(EN) · Xinmei Shen ·

    ByteDance spin-off Anew Labs raises US$290m as AI drug developers enjoy fundraising boom

    China is seeing a fresh fundraising boom for artificial intelligence-powered drug developers, with start-ups including a ByteDance spin-off raising hundreds of millions of dollars this week as investors rush to back domestic challengers to Anthropic and Isomorphic Labs. Anew Labs…

RELATED ENTITIES

RELATED TOPICS